Dr. Elizabeth Berry-Kravis, MD, PhD
Claim this profileRush University Medical Center
Studies Syndrome
Studies Fragile X Syndrome
8 reported clinical trials
11 drugs studied
Area of expertise
1Syndrome
FMR1 positive
FMR1
MECP2 positive
2Fragile X Syndrome
FMR1 positive
FMR1
Affiliated Hospitals
Clinical Trials Elizabeth Berry-Kravis, MD, PhD is currently running
Zatolmilast
for Fragile X Syndrome
This trial is testing a medication called BPN14770 in boys with fragile X syndrome. The study aims to see how the medication moves through their bodies and if it helps with their symptoms.
Recruiting0 awards Phase 2 & 3
Cannabidiol Gel
for Fragile X Syndrome
This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.
Recruiting1 award Phase 311 criteria
More about Elizabeth Berry-Kravis, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Elizabeth Berry-Kravis, MD, PhD has experience with
- Placebo
- Arimoclomol
- N/A
- Ketamine
- Observational Study
- TSHA-102
Breakdown of trials Elizabeth Berry-Kravis, MD, PhD has run
Syndrome
Fragile X Syndrome
Rett Syndrome
Niemann-Pick Disease
Primary Progressive Aphasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth Berry-Kravis, MD, PhD specialize in?
Elizabeth Berry-Kravis, MD, PhD focuses on Syndrome and Fragile X Syndrome. In particular, much of their work with Syndrome has involved FMR1 positive patients, or patients who are FMR1.
Is Elizabeth Berry-Kravis, MD, PhD currently recruiting for clinical trials?
Yes, Elizabeth Berry-Kravis, MD, PhD is currently recruiting for 4 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth Berry-Kravis, MD, PhD has studied deeply?
Yes, Elizabeth Berry-Kravis, MD, PhD has studied treatments such as Placebo, Arimoclomol, N/A.
What is the best way to schedule an appointment with Elizabeth Berry-Kravis, MD, PhD?
Apply for one of the trials that Elizabeth Berry-Kravis, MD, PhD is conducting.
What is the office address of Elizabeth Berry-Kravis, MD, PhD?
The office of Elizabeth Berry-Kravis, MD, PhD is located at: Rush University Medical Center, Chicago, Illinois 60612 United States. This is the address for their practice at the Rush University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.